We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$634M
AUM Growth
+$63M
(+11%)
Cap. Flow
+$39.2M
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
49.16%
Holding
384
New
40
Increased
108
Reduced
134
Closed
49
Avg Time Held
2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$57.2M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$48.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$39.3M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$33M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$33M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$32.1M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$25.8M |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$23.9M |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$17.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 72.19% |
| 2 | Financials | 3.87% |
| 3 | Industrials | 3.84% |
| 4 | Technology | 3.44% |
| 5 | Healthcare | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Wells Fargo
WFC
$253B
| $426K | 0.07% |
7,651
+226
| +3% | +$12.8K |
2013 Q2
15 quarters
|
|
152
ProShares UltraPro QQQ
TQQQ
$34.9B
| $423K | 0.07% |
115,200
| – | – |
2016 Q3
2 quarters
|
|
153
WisdomTree International MidCap Dividend Fund
DIM
$160M
| $418K | 0.07% |
6,950
+450
| +7% | +$26.2K |
2013 Q4
13 quarters
|
|
|
154
iShares Russell 3000 ETF
IWV
$20.4B
| $366K | 0.06% |
2,618
-126,566
| -98% | -$17.5M |
2013 Q2
15 quarters
|
|
155
Bristol-Myers Squibb
BMY
$124B
| $347K | 0.05% |
6,373
+160
| +3% | +$8.78K |
2015 Q4
5 quarters
|
|
|
CMD
156
DELISTED
Cantel Medical Corporation
CMD
| $337K | 0.05% |
4,205
-410
| -9% | -$32.6K |
2014 Q3
10 quarters
|
|
157
ExxonMobil
XOM
$724B
| $333K | 0.05% |
4,060
+295
| +8% | +$24.6K |
2013 Q2
15 quarters
|
|
158
NXP Semiconductors
NXPI
$59.2B
| $292K | 0.05% |
2,825
-760
| -21% | -$76.8K |
2014 Q4
9 quarters
|
|
159
Aon
AON
$61.3B
| $287K | 0.05% |
2,415
-490
| -17% | -$56.5K |
2013 Q2
15 quarters
|
|
160
Tyler Technologies
TYL
$14.7B
| $263K | 0.04% |
1,700
+230
| +16% | +$35K |
2016 Q1
4 quarters
|
|
161
NewMarket
NEU
$8.16B
| $258K | 0.04% |
569
-145
| -20% | -$63.5K |
2013 Q2
15 quarters
|
|
162
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $257K | 0.04% |
7,376
-5,060
| -41% | -$174K |
2015 Q2
7 quarters
|
|
163
Columbia Emerging Markets Consumer ETF
ECON
$296M
| $250K | 0.04% |
10,080
+500
| +5% | +$12K |
2015 Q3
6 quarters
|
|
164
iShares Biotechnology ETF
IBB
$10.5B
| $249K | 0.04% |
+2,550
| New | +$244K |
2017 Q1
0 quarters
|
|
165
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.4B
| $248K | 0.04% |
1,200
-1,325
| -52% | -$270K |
2016 Q4
1 quarter
|
|
166
Oracle
ORCL
$396B
| $244K | 0.04% |
5,477
-314
| -5% | -$13.1K |
2013 Q2
15 quarters
|
|
167
Watsco Inc
WSO
$12.2B
| $236K | 0.04% |
1,645
-480
| -23% | -$71.9K |
2013 Q2
15 quarters
|
|
168
Manhattan Associates
MANH
$13.1B
| $232K | 0.04% |
4,465
-735
| -14% | -$37.1K |
2016 Q2
3 quarters
|
|
169
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.4B
| $230K | 0.04% |
1,631
-1,216
| -43% | -$168K |
2015 Q2
7 quarters
|
|
|
RDS.B
170
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $228K | 0.04% |
4,080
-85
| -2% | -$4.82K |
2016 Q4
1 quarter
|
|
171
National Beverage
FIZZ
$3.22B
| $228K | 0.04% |
5,386
-1,574
| -23% | -$47.4K |
2016 Q3
2 quarters
|
|
172
DELISTED
Unilever NV New York Registry Shares
UN
| $224K | 0.04% |
4,511
+2,396
| +113% | +$107K |
2013 Q4
13 quarters
|
|
173
State Street SPDR S&P Regional Banking ETF
KRE
$3.35B
| $218K | 0.03% |
4,000
| – | – |
2016 Q4
1 quarter
|
|
174
Halliburton
HAL
$27.9B
| $218K | 0.03% |
4,431
+129
| +3% | +$6.94K |
2013 Q2
15 quarters
|
|
175
Direxion Daily Healthcare Bull 3X ETF
CURE
$187M
| $207K | 0.03% |
6,000
| – | – |
2016 Q3
2 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q1 2017 Portfolio in Review
As of Q1 2017, Capital Analysts LLC held 384 positions worth $634M, up 11% from $571M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Capital Analysts LLC deployed $39.2M of net new capital in Q1 2017, opening 40 new positions and adding to 108 existing holdings. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 618,037 shares worth $33.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, up from 69% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares S&P 500 Value ETF, an estimated $33M trimmed.
- Capital Analysts LLC's largest Q1 2017 buy was iShares Core S&P Total US Stock Market ETF: 618,037 shares worth $33.4M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q1 2017, an estimated $57.2M increase.
- Capital Analysts LLC's biggest Q1 2017 reduction was iShares S&P 500 Value ETF, cutting an estimated $33M.
- Capital Analysts LLC fully exited iShares MBS ETF in Q1 2017, selling an estimated $5.37M.
- Capital Analysts LLC's ten largest holdings make up 49% of its $634M portfolio in Q1 2017.
- Capital Analysts LLC opened 40 new positions and closed 49 in Q1 2017.
- Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $634M.
Based on Capital Analysts LLC's 13F filing for Q1 2017, filed 5 May 2017.